GeneNews Announces Election of Directors
TORONTO, May 30, 2013 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN)
("GeneNews" or the "Company") announces that the nominees listed in the
management information circular for the annual and special meeting (the
"Meeting") of shareholders held on Tuesday, May 28, 2013 were elected as
directors of GeneNews.
Detailed results of the vote for the election of directors are set out below.
Nominees Votes FOR % FOR Votes WITHHELD % WITHHELD
Heiner Dreismann 13,382,089 99.48 69,432 0.52
Gailina Liew 13,382,089 99.48 69,432 0.52
Rory Riggs 13,382,089 99.48 69,432 0.52
Garth MacRae 13,382,089 99.48 69,432 0.52
David Sable 13,382,089 99.48 69,432 0.52
Harry Glorikian 13,382,089 99.48 69,432 0.52
James Howard-Tripp 13,382,089 99.48 69,432 0.52
GeneNews is a molecular diagnostics company focused on developing and
commercializing proprietary blood-based diagnostic tests through the
application of functional genomics to enable early diagnosis and personalized
health management. The Company has developed a patented core platform
technology, the Sentinel Principle^®, which has the power to detect and stage
virtually any disease or medical condition from a simple blood sample.
GeneNews has applied the Sentinel Principle^® in major areas with unmet
clinical needs such as cancer, arthritis, cardiovascular disease and
neurological disorders. GeneNews' lead product, ColonSentry^®, is the world's
first blood test to assess an individual's current risk for colorectal cancer.
For more information on GeneNews and ColonSentry^®, go to www.GeneNews.com or
This press release contains forward-looking statements, which reflect the
Company's current expectations regarding future events. The forward-looking
statements involve risks and uncertainties. Actual events could differ
materially from those projected herein. Investors should consult the Company's
ongoing quarterly filings and annual reports for additional information on
risks and uncertainties relating to these forward-looking statements. The
reader is cautioned not to rely on these forward-looking statements. The
Company disclaims any obligation to update these forward-looking statements.
CONTACT: Company Contact:
President & COO
Office: (905) 739-2036
Mobile: (416) 844-0649
Investor & Media Contact:
Kilmer Lucas Inc.
Office: (212) 618-6347
Mobile: (905) 906-6908
Press spacebar to pause and continue. Press esc to stop.